Bernot, K M <br/><br/>
Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.  [electronic resource] 

 -  Leukemia  Dec 2013 
 - 2379-82 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2013.147  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Epigenesis, Genetic<br/>Histone-Lysine N-Methyltransferase<br/>Humans<br/>Leukemia, Myeloid, Acute--genetics<br/>Mice<br/>Mice, Knockout<br/>Myeloid-Lymphoid Leukemia Protein--genetics<br/>Precision Medicine